KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

Mumbai: Emcure Pharmaceuticals Ltd. and Sanofi India Limited have entered into an exclusive distribution and promotion ...

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Emcure signs exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic brands Amaryl and Cetapin ...

Emcure Pharmaceuticals and Sanofi India have entered into a distribution agreement to promote Sanofi's oral anti-diabetic products, Amaryl and Cetapin, across India.

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...